Ozempic Dosing Guide: What is the Next Dose After 1 mg and Beyond?

Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide dosing typically follows a 16-week escalation protocol, but many patients wonder what comes after the 1 mg milestone and whether dose increases truly optimize results. Clinical trials show that response to GLP-1 therapy varies significantly between individuals, influenced by genetics, metabolism, and individual weight loss plateaus. PlexusDx provides personalized guidance to help you understand where your treatment should go next.

Understanding Semaglutide Dose Progression Beyond 1 mg

Semaglutide typically begins at 0.25 mg weekly and advances through 0.5 mg, 0.75 mg, and 1 mg over consecutive weeks. Once patients reach the 1 mg dose, treatment usually continues at this maintenance level for ongoing weight management. However, some individuals experience a plateau in weight loss and may benefit from dose adjustment based on tolerability and clinical response. The decision to increase, maintain, or modify your dose depends on how your body responds, your individual health goals, and any side effects you're experiencing.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

When and Why Patients Move Beyond 1 mg Semaglutide

Weight loss velocity often decreases after 12–16 weeks of therapy, a pattern called a plateau phase that prompts clinicians to consider dose adjustments. Some patients reach their target weight loss at 1 mg, while others continue to lose weight at higher doses, up to 2.4 mg weekly. Research from the STEP trials demonstrated that higher doses of semaglutide (2.4 mg) produced greater reductions in body weight compared to 1 mg, with an average difference of 2–3% additional weight loss. Your individual response depends on factors like starting weight, metabolic rate, adherence, lifestyle changes, and genetic variation in GLP-1 receptor sensitivity.

Discontinuing at 1 mg is a valid clinical option if you've achieved your weight loss goals and feel satisfied with results. Conversely, if you experience minimal appetite suppression or plateauing weight loss after 8–12 weeks at maintenance, your provider may recommend exploring higher doses or alternative compounds like tirzepatide.

Genetic Factors That Influence Your Optimal Semaglutide Dose

The PlexusDx Precision Peptide Genetic Test analyzes FTO (rs9939609) and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Understanding your genetic predisposition to GLP-1 sensitivity helps avoid unnecessary dose increases, reduces the risk of excessive side effects, and accelerates your path to sustainable weight loss. PlexusDx recommends considering the Precision Peptide Genetic Test after your first month of treatment to inform your long-term dosing strategy and confirm whether continuation at 1 mg or escalation beyond it makes sense for your unique biology.

Maintenance vs. Escalation: Creating Your Personalized Plan

Three primary dosing strategies exist after reaching 1 mg: indefinite maintenance at that level, gradual escalation to 1.5–2.4 mg, or rotation to a complementary compound. Maintenance works best for patients who've achieved meaningful weight loss, tolerate the medication well, and lack a strong clinical reason to increase further. Escalation is appropriate when weight loss has stalled for 4+ weeks, side effects are minimal, and your provider identifies room for improvement in your outcomes.

PlexusDx Semaglutide Injection ($189/mo flat) allows seamless dose titration without adding to your monthly cost, giving you the flexibility to increase strength as your provider recommends. For patients seeking enhanced results beyond semaglutide alone, PlexusDx also offers GLP-Squared Injection (a dual compound combining semaglutide and tirzepatide) at $289/mo month-to-month, or from $249/mo on the 6-month plan, or tirzepatide monotherapy at $289/mo, each available from licensed 503A compounding pharmacies serving all 50 states without insurance requirements.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is 1 mg the highest dose of semaglutide available?

No. While 1 mg is a common maintenance dose, semaglutide dosing can extend to 2.4 mg weekly for enhanced weight loss in certain populations. PlexusDx offers compounded semaglutide injection from licensed 503A compounding pharmacies with flexibility to titrate beyond 1 mg based on your provider's assessment and your individual response.

What does clinical data show about dose increases after 1 mg?

The STEP trials demonstrated that escalating from 1 mg to 2.4 mg produced an additional 2–3% body weight reduction on average. However, not all patients benefit from escalation; some achieve their goals at 1 mg, while others experience diminishing returns or increased side effects at higher doses.

Will my PlexusDx pricing change if my dose increases?

No. PlexusDx maintains flat monthly pricing across all dose levels—your semaglutide injection stays at $189/mo (or $149/mo on the 6-month plan) whether you titrate to 1.5 mg, 2 mg, or 2.4 mg. Your dose may need to go up. Your price won't.

What are the common side effects at higher semaglutide doses?

Nausea, vomiting, constipation, and gastric distress increase in frequency and intensity at higher doses, typically peaking during titration and subsiding as your body adapts. If side effects become intolerable at doses above 1 mg, your provider may recommend staying at 1 mg or switching to an alternative compound like oral semaglutide or tirzepatide.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Glp 1 Starting Dose
• Ozempic Starting Dose
• Ozempic Dosing
• Maximus Glp 1

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.